Logo image of LEO

BNY MELLON STRATEGIC MUNI (LEO) Stock Overview

NYSE:LEO - US05588W1080

5.89 USD
+0.01 (+0.17%)
Last: 8/28/2025, 8:22:52 PM
Fundamental Rating

1

Overall LEO gets a fundamental rating of 1 out of 10. We evaluated LEO against 0 industry peers in the Unkown industry. Both the profitability and financial health of LEO have multiple concerns. LEO has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

LEO had positive earnings in the past year.
LEO had a negative operating cash flow in the past year.
LEO had positive earnings in 4 of the past 5 years.
LEO had a positive operating cash flow in each of the past 5 years.
LEO Yearly Net Income VS EBIT VS OCF VS FCFLEO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

Industry RankSector Rank
ROA 0.3%
ROE 0.47%
ROIC 2.07%
ROA(3y)-1.88%
ROA(5y)0.19%
ROE(3y)-2.09%
ROE(5y)0.49%
ROIC(3y)2.36%
ROIC(5y)2.42%
LEO Yearly ROA, ROE, ROICLEO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

LEO's Profit Margin has improved in the last couple of years.
LEO's Operating Margin has declined in the last couple of years.
LEO's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 59.07%
PM (TTM) 6.9%
GM 70.41%
OM growth 3Y-11.93%
OM growth 5Y-6.05%
PM growth 3Y19.55%
PM growth 5Y13.32%
GM growth 3Y-9.6%
GM growth 5Y-4.17%
LEO Yearly Profit, Operating, Gross MarginsLEO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200

More info and screens

1

2. Health

2.1 Basic Checks

The number of shares outstanding for LEO has been reduced compared to 1 year ago.
The number of shares outstanding for LEO has been reduced compared to 5 years ago.
LEO has a worse debt/assets ratio than last year.
LEO Yearly Shares OutstandingLEO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
LEO Yearly Total Debt VS Total AssetsLEO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

LEO has an Altman-Z score of 0.90. This is a bad value and indicates that LEO is not financially healthy and even has some risk of bankruptcy.
LEO has a Debt/Equity ratio of 0.54. This is a neutral value indicating LEO is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.54
Debt/FCF N/A
Altman-Z 0.9
ROIC/WACCN/A
WACCN/A
LEO Yearly LT Debt VS Equity VS FCFLEO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.3 Liquidity

A Current Ratio of 0.51 indicates that LEO may have some problems paying its short term obligations.
A Quick Ratio of 0.51 indicates that LEO may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.51
Quick Ratio 0.51
LEO Yearly Current Assets VS Current LiabilitesLEO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for LEO have decreased strongly by -87.50% in the last year.
LEO shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 7.55% yearly.
LEO shows a small growth in Revenue. In the last year, the Revenue has grown by 3.76%.
The Revenue has been decreasing by -5.00% on average over the past years.
EPS 1Y (TTM)-87.5%
EPS 3Y15.79%
EPS 5Y7.55%
EPS Q2Q%-140.74%
Revenue 1Y (TTM)3.76%
Revenue growth 3Y-2.83%
Revenue growth 5Y-5%
Sales Q2Q%7.14%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
LEO Yearly Revenue VS EstimatesLEO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

LEO is valuated quite expensively with a Price/Earnings ratio of 147.25.
The average S&P500 Price/Earnings ratio is at 27.17. LEO is valued rather expensively when compared to this.
Industry RankSector Rank
PE 147.25
Fwd PE N/A
LEO Price Earnings VS Forward Price EarningsLEO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LEO Per share dataLEO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)19.5
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

LEO has a Yearly Dividend Yield of 4.03%, which is a nice return.
Compared to an average S&P500 Dividend Yield of 2.34, LEO pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.03%

5.2 History

The dividend of LEO decreases each year by -11.71%.
LEO has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-11.71%
Div Incr Years0
Div Non Decr Years0
LEO Yearly Dividends per shareLEO Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.1 0.2 0.3 0.4

5.3 Sustainability

LEO pays out 759.00% of its income as dividend. This is not a sustainable payout ratio.
DP759%
EPS Next 2YN/A
EPS Next 3YN/A
LEO Yearly Income VS Free CF VS DividendLEO Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M
LEO Dividend Payout.LEO Dividend Payout, showing the Payout Ratio.LEO Dividend Payout.PayoutRetained Earnings

More info and screens

BNY MELLON STRATEGIC MUNI

NYSE:LEO (8/28/2025, 8:22:52 PM)

5.89

+0.01 (+0.17%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)11-23 2023-11-23
Earnings (Next)N/A N/A
Inst Owners43.35%
Inst Owner Change6.26%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap366.89M
Analysts0
Price TargetN/A
Short Float %0.14%
Short Ratio0.55
Dividend
Industry RankSector Rank
Dividend Yield 4.03%
Yearly Dividend0.23
Dividend Growth(5Y)-11.71%
DP759%
Div Incr Years0
Div Non Decr Years0
Ex-Date08-13 2025-08-13 (0.023)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 147.25
Fwd PE N/A
P/S 12.65
P/FCF N/A
P/OCF N/A
P/B 0.87
P/tB 0.87
EV/EBITDA N/A
EPS(TTM)0.04
EY0.68%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.37
FCFYN/A
OCF(TTM)-0.37
OCFYN/A
SpS0.47
BVpS6.81
TBVpS6.81
PEG (NY)N/A
PEG (5Y)19.5
Profitability
Industry RankSector Rank
ROA 0.3%
ROE 0.47%
ROCE 2.62%
ROIC 2.07%
ROICexc 2.07%
ROICexgc 2.07%
OM 59.07%
PM (TTM) 6.9%
GM 70.41%
FCFM N/A
ROA(3y)-1.88%
ROA(5y)0.19%
ROE(3y)-2.09%
ROE(5y)0.49%
ROIC(3y)2.36%
ROIC(5y)2.42%
ROICexc(3y)2.38%
ROICexc(5y)2.43%
ROICexgc(3y)2.38%
ROICexgc(5y)2.43%
ROCE(3y)2.99%
ROCE(5y)3.07%
ROICexcg growth 3Y-8.62%
ROICexcg growth 5Y-6.1%
ROICexc growth 3Y-8.62%
ROICexc growth 5Y-6.1%
OM growth 3Y-11.93%
OM growth 5Y-6.05%
PM growth 3Y19.55%
PM growth 5Y13.32%
GM growth 3Y-9.6%
GM growth 5Y-4.17%
F-Score1
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.54
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.51
Quick Ratio 0.51
Altman-Z 0.9
F-Score1
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-87.5%
EPS 3Y15.79%
EPS 5Y7.55%
EPS Q2Q%-140.74%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)3.76%
Revenue growth 3Y-2.83%
Revenue growth 5Y-5%
Sales Q2Q%7.14%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y3.57%
EBIT growth 3Y-14.42%
EBIT growth 5Y-10.75%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-142.84%
FCF growth 3Y-37.21%
FCF growth 5Y-16.22%
OCF growth 1Y-142.84%
OCF growth 3Y-37.21%
OCF growth 5Y-16.22%